開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
Microsoft (MSFT.O) rose 3.6% after reports it will release a new coding model next week.
2026-05-28
Microsoft (MSFT.O) rose 3.6% after reports it will release a new coding model next week.
返回
其他消息
2026-05-28
At a May 28 regular press briefing, the Ministry of Natural Resources published and explained the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs and Functional Products. On intellectual property protection, Yu Jiangyong, deputy director of the Drugs Registration Management Department at the National Medical Products Administration (NMPA), said the NMPA and the China National Intellectual Property Administration (CNIPA) have established an early-resolution mechanism for
At a May 28 regular press briefing, the Ministry of Natural Resources published and explained the Guiding Opinions on Accelerating High-Quality Development of Marine Drugs and Functional Products. On intellectual property protection, Yu Jiangyong, deputy director of the Drugs Registration Management Department at the National Medical Products Administration (NMPA), said the NMPA and the China National Intellectual Property Administration (CNIPA) have established an early-resolution mechanism for drug patent disputes. The newly revised Implementing Regulations of the PRC Drug Administration Law (the Regulations) further strengthen protection for drug trial data and establish a market exclusivity-period system for pediatric medicines and drugs for rare diseases. The Measures for the Protection of Drug Trial Data took effect simultaneously with the Regulations on May 15, and the Regulations’ specific implementation documents for the market exclusivity system are currently being intensively drafted. NMPA said these measures will further bolster IP protection for innovative drugs and stimulate firms’ innovation momentum in marine drug R&D.
2026-05-28
韓國央行:預計2026年通脹爲2.7%,此前預期爲2.2%;預計2027年通脹率爲2.3%。
韓國央行:預計2026年通脹爲2.7%,此前預期爲2.2%;預計2027年通脹率爲2.3%。
Chat with us
, powered by
LiveChat